Our research focuses on key biological pathways involved in fibrotic scarring, which may lead to a more precise approach to halting disease progression.
Our ultimate goal is developing therapies with improved safety profiles to help patients stay on treatment and maintain quality of life.
Our innovative platform explores opportunities to not only prevent scarring but support lung tissue repair and regeneration.